Skip to main content
. 2017 Oct 30;22(2):728–737. doi: 10.1111/jcmm.13407

Figure 2.

Figure 2

Target cell and effective molecules (miRNA) in EVs‐based therapy of kidney injury are schematically summarized. EVs: extracellular vesicles; MSCs: mesenchymal stem cells; ECFCs: endothelial colony‐forming cells; EndoMT: endothelial‐to‐mesenchymal transition; EMT: epithelial–mesenchymal transition.